This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Je Il Pharmaceutical Co., Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Yoonsun Park: Innovator in Imidazo[1,2-A]pyridine Derivatives
Introduction
Yoonsun Park is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds.
Latest Patents
Yoonsun Park holds a patent for "Imidazo[1,2-A]pyridine derivatives, methods for preparing the same and use thereof." This patent focuses on innovative imidazo[1,2-a]pyridine derivatives, specifically those of Formula 1. The disclosure highlights the methods for preparing these compounds and their potential applications.
Career Highlights
Yoonsun Park is associated with Je Il Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has contributed to the pharmaceutical industry, enhancing the understanding and application of imidazo[1,2-a]pyridine derivatives.
Collaborations
Yoonsun Park collaborates with talented colleagues, including Jeongmin Kim and Hyunho Lee. These partnerships foster a dynamic research environment that encourages innovation and discovery.
Conclusion
Yoonsun Park's contributions to the field of chemistry, particularly through his patent on imidazo[1,2-a]pyridine derivatives, showcase his innovative spirit and dedication to advancing pharmaceutical research. His work continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile